Live Chart






Laurus Labs Ltd Overview

Days Range

Low: ₹333.05
High: ₹345.00
Previous Close ₹330.70
Open ₹334.65
Volume 69,86,665
Day’s Range ₹333.05 - ₹345.00
52W Range ₹278.85 - ₹605.50
Market Cap ₹18,332 Cr

Fundamentals of Laurus Labs Ltd

ROCE (TTM) 20.32%
P/E Ratio (TTM) 23.2
P/B Ratio 4.54
Industry P/E 29
Debt to Equity 0.5
ROE 19.57%
EPS (TTM) 14.67
Dividend Yield 0.35%
Book Value 75
Face Value 2

Financials of Laurus Labs Ltd

Jun 2022Sep 2022Dec 2022Mar 2023
Net Sales1,538.941,575.891,544.821,380.9
Profit before tax355.88328.07277.85147.14
Operating Profit252.54233.8203.06107.24
Net Profit252.54233.8203.06107.24
EPS in Rs4.684.333.781.9

About Laurus Labs Ltd

Laurus Labs is a fully integrated pharmaceutical and biotechnology company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of a ... Read More

Parent Organisation Indian Private
Founded 2005
Managing Director M Venu Gopala Rao

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Lupin Ltd ₹36,928.33


7.65 (0.95%)

805 - 817.35
Syngene International Ltd ₹29,212.42


1.55 (0.21%)

720 - 729.65
Alkem Laboratories Ltd ₹40,395.63


20.75 (0.62%)

3366.45 - 3418.75
Glaxosmithkline Pharmaceuticals Ltd ₹22,486.11


21.85 (1.67%)

1305.35 - 1339.3
Zydus Lifesciences Ltd ₹51,961.50


11.10 (2.21%)

500.8 - 514.4

What's Trending


What is the Share price of Laurus Labs Ltd (LAURUSLABS)?

Laurus Labs Ltd (LAURUSLABS) share price as of June 1, 2023, on NSE is Rs 340.50 (NSE) and Rs 340.35 (BSE) on BSE.

Can I buy Laurus Labs Ltd (LAURUSLABS) shares?

Yes, You can buy Laurus Labs Ltd (LAURUSLABS) shares by opening a Demat account with Angel One.

How do I buy Laurus Labs Ltd (LAURUSLABS) from Angel One?

Laurus Labs Ltd (LAURUSLABS) share can be brought through the following modes:
  1. Direct investment: You can buy Laurus Labs Ltd (LAURUSLABS) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Laurus Labs Ltd (LAURUSLABS) shares.

Is Laurus Labs a Debt free Company?

No, Laurus Labs is not a debt free company.

What is the main business of Laurus Labs?

The main business of Laurus Labs is to research, manufacture, and sell pharmaceutical and biotechnology-related products with a special emphasis on Hepatitis C, anti-retroviral, and oncology drugs. It also sells its generic APIs in 56 countries along with generic FDF.

Who are the promoters of Laurus Labs?

Some of the main promoters of Laurus Labs are M/s. NSN Holdings (Represented by its Managing Partner, Dr. Satyanarayana Chava), Chava Naga Rani, Satyanarayana Chava, Chunduru Venkata Lakshmana Rao, Venkata Ravi Kumar Vantaram, Hymavathi Vantaram, Rama Suryadevara, and Krishnaveni Vasireddi.

What are the Subsidiaries that comes under Laurus Labs?

The main subsidiaries that come under Laurus Labs are Laurus Generics Inc., USA, Sriram Labs Pvt. Ltd., Laurus Holdings Ltd., Laurus Ingredients Pvt. Ltd., Laurus Generics Gmbh, Laurus Generics SA (Pty) Ltd., and Laurus Bio Private Ltd. (formerly known as Richcore Lifesciences Pvt. Ltd.).